Tolero Pharmaceuticals
A biopharmaceutical company, develops novel therapeutics to treat cancer and other life-threatening diseases.
Launch date
Employees
Market cap
-
Enterprise valuation
AUD51—76m (Dealroom.co estimates Nov 2014.)
Salt Lake City Utah (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | $3.3m | Debt | |
| N/A | $200k | Grant | |
$14.2m | Series B | ||
$8.2m | Series B | ||
$780m | Acquisition | ||
| Total Funding | AUD34.9m | ||
Recent News about Tolero Pharmaceuticals
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.